Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01036581 · ClinicalTrials.gov registry record · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
A NA study of Nicotine Dependence and Drug Abuse, sponsored by National Institute on Drug Abuse (NIDA).
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT01036581: Recruiting NA study of Nicotine Dependence and Drug Abuse, sponsored by National Institute on Drug Abuse (NIDA).
NCT01036581 is a NA study of Nicotine Dependence and Drug Abuse that is actively recruiting participants, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 1,000 participants, above the 172-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (481% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01036581, a NA study of Nicotine Dependence and Drug Abuse, is actively recruiting participants, sponsored by National Institute on Drug Abuse (NIDA).
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Functional and structural magnetic resonance imaging (MRI) techniques have allowed researchers to map and study how the brain works when at rest and when engaged in specific tasks. MRI scans have provided more information about how drugs affect the brain, and about how drug addiction changes the brain and influences behavior, mood, and thinking processes. To better understand the underlying mechanism of drug addiction and to develop strategies for more effective treatment, researchers are interested in developing new MRI techniques to study the effects of addiction on the brain. Objectives: \- To develop new functional and structural MRI techniques, and to evaluate their potential use in brain imaging studies related to addiction. Eligibility: * Individuals between 18 and 80 years of age. * Participants may be smokers or nonsmokers, and may use drugs or not use drugs. Design: * During the initial screening, participants will complete questionnaires about family and personal history, drug use, and other information as required by the researchers. Participants who will be asked to complete tasks during the MRI scan will be shown how to perform these tasks before the scanning session. * Before each study session, participants may be asked to complete some or all of the following: questions about their drug use during the last week, a breathalyzer test, a urine drug-use assessment, a urine pregnancy test, or a measure of carbon monoxide. Participants will also provide blood samples before the start of the scan. * For each scanning session, participants will have an MRI scan that will last approximately 2 hours. * MRI scans may include specific tasks to be performed during the scan, or an experiment that studies the brain's response to carbon dioxide....
Primary Outcome
perfusion/BOLD imaging data
Conditions Studied
Interventions
- DEVICE MagPro X100 Magnetic Stimulator
- DEVICE Transcranial Rotating Magnetic Stimulator
- DEVICE Magnetom Prisma Fit 3T Scanner
Study Locations (1)
Maryland
- National Institute on Drug Abuse, Biomedical Research Center (BRC) - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2003-10-24 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
What NCT01036581 shows while recruiting
NCT01036581 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 172-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (481% higher).
The record links to 2 conditions, with Nicotine Dependence appearing as the primary indexed condition, and to 3 interventions - of which MagPro X100 Magnetic Stimulator is the first listed.
NCT01036581 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01036581 about?
NCT01036581 is a clinical study titled "Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging". Background: \- Functional and structural magnetic resonance imaging (MRI) techniques have allowed researchers to map and study how the brain works when at rest and when engaged in specific tasks. MRI scans have provided more information about how drugs affect the brain, and about how drug addiction...
What is the current status of trial NCT01036581?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2003-10-24. Estimated completion is 2029-12-31.
What conditions does trial NCT01036581 study?
This clinical trial studies the following conditions: Nicotine Dependence, Drug Abuse.
What interventions are being tested in trial NCT01036581?
The interventions under investigation include: MagPro X100 Magnetic Stimulator (DEVICE), Transcranial Rotating Magnetic Stimulator (DEVICE), Magnetom Prisma Fit 3T Scanner (DEVICE).
Who is sponsoring clinical trial NCT01036581?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01036581 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01036581's enrollment target sits among peer trials
1,000 2nd of 67 the highest of 67 other Nicotine Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nicotine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
RECRUITING · NA
-
NeuroControl of Nicotine Dependence
RECRUITING · NA
-
Abuse Liability and Appeal of Oral Nicotine Products
RECRUITING · NA
-
Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction
RECRUITING · NA
-
Young Adult Tobacco/Nicotine and Cannabis Co-use
RECRUITING · NA
-
Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
- NCT02090530 · 1,000 participants
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI